Quarterly ResultOct 28, 2026, 06:11 AM
Avantor Q3 Sales Up 4.6% to $1.7B; Raises FY26 Guidance
AI Summary
Avantor, Inc. announced its third quarter 2026 financial results, reporting net sales of $1,698.3 million, a 4.6% increase year-over-year, with organic growth of 5.2%. The company exceeded management's expectations for revenue and adjusted EPS. Avantor also raised its full-year 2026 guidance for organic revenue growth, adjusted EPS, and free cash flow, signaling improved performance and outlook. Both VWR Distribution & Services and Bioscience & Medtech Products segments contributed to the growth.
Key Highlights
- Avantor reported Q3 2026 net sales of $1,698.3 million, a 4.6% increase year-over-year (5.2% organic growth).
- Diluted GAAP EPS was $0.30, while adjusted EPS was $0.22.
- Raised FY 2026 guidance for organic revenue growth to +0.75% to +1.25%, adjusted EPS to $0.81-$0.83, and free cash flow to $525M-$550M.
- VWR Distribution & Services net sales increased 5.0% (5.8% organic), while Bioscience & Medtech Products net sales increased 3.5% (3.6% organic).
- Free cash flow for Q3 2026 was $156.2 million.
- Total debt, gross was $3,699.7 million and cash and cash equivalents were $464.3 million as of September 30, 2026.
Price Impact
More from AVTR